| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 159, Issue 7 3104-3108, Copyright © 1997 by American Association of Immunologists
CUTTING EDGE |
DI Daikh, BK Finck, PS Linsley, D Hollenbaugh and D Wofsy
Department of Medicine, Department of Veterans Affairs Medical Center, San Francisco, CA 94121, USA. daikh@itsa.ucsf.edu
Murine lupus in NZB/NZW F1 (B/W) mice can be retarded by sustained administration of CTLA4Ig and by brief treatment early in life with mAb that block CD40/gp39 interactions. We sought to determine whether brief therapy with CTLA4Ig could provide sustained benefit in B/W mice and whether a synergistic effect could be derived by blockade of both the B7/CD28 and the CD40/gp39 pathways. We found that a short course of CTLA4Ig at the onset of disease produced only short-term benefit. However, when CTLA4Ig was combined with anti-gp39, there was long- lasting inhibition of autoantibody production and renal disease. Ten months after the 2-wk course of therapy, 70% of these mice were alive, compared with only 18% and 0% of those that received only anti-gp39 or CTLA4Ig, respectively. These findings demonstrate that brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways can produce benefit that lasts long after treatment has been discontinued.
This article has been cited by other articles:
|
|
 |
|
  J. D. Isaacs Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future Rheumatology, October 1, 2008; 47(10): 1461 - 1468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nolan, M. Weiden, A. Kelly, Y. Hoshino, S. Hoshino, N. Mehta, and J. A. Gold CD40 and CD80/86 Act Synergistically to Regulate Inflammation and Mortality in Polymicrobial Sepsis Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 301 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-C. Hsu, Y. Wu, P. Yang, Q. Wu, G. Job, J. Chen, J. Wang, M. A. V. Accavitti-Loper, W. E. Grizzle, R. H. Carter, et al. Overexpression of Activation-Induced Cytidine Deaminase in B Cells Is Associated with Production of Highly Pathogenic Autoantibodies J. Immunol., April 15, 2007; 178(8): 5357 - 5365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Davidson, B Diamond, D Wofsy, and D Daikh Block and tackle: CTLA4Ig takes on lupus Lupus, March 1, 2005; 14(3): 197 - 203. [Abstract] [PDF]
|
|
|
|
|
|
K. M. Pollard, M. Arnush, P. Hultman, and D. H. Kono Costimulation Requirements of Induced Murine Systemic Autoimmune Disease J. Immunol., November 1, 2004; 173(9): 5880 - 5887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C G Parks, L L Hudson, G S Cooper, M A Dooley, E L Treadwell, E W St Clair, G S Gilkeson, and J P Pandey CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States Lupus, October 1, 2004; 13(10): 784 - 791. [Abstract] [PDF]
|
|
|
|
 |
|
 D. M. Tarlinton and P. D. Hodgkin Targeting Plasma Cells in Autoimmune Diseases J. Exp. Med., June 7, 2004; 199(11): 1451 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Yazdany and J Davis The role of CD40 ligand in systemic lupus erythematosus Lupus, May 1, 2004; 13(5): 377 - 380. [Abstract] [PDF]
|
|
|
|
|
|
H. Iwai, M. Abe, S. Hirose, F. Tsushima, K. Tezuka, H. Akiba, H. Yagita, K. Okumura, H. Kohsaka, N. Miyasaka, et al. Involvement of Inducible Costimulator-B7 Homologous Protein Costimulatory Pathway in Murine Lupus Nephritis J. Immunol., September 15, 2003; 171(6): 2848 - 2854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C P Mavragani and H M Moutsopoulos Lupus nephritis: current issues Ann Rheum Dis, September 1, 2003; 62(9): 795 - 798. [Full Text] [PDF]
|
|
|
|
|
|
C C Mok, R W S Wong, and K N Lai Treatment of severe proliferative lupus nephritis: the current state Ann Rheum Dis, September 1, 2003; 62(9): 799 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Schiffer, J. Sinha, X. Wang, W. Huang, G. von Gonsdorff, M. Schiffer, M. P. Madaio, and A. Davidson Short Term Administration of Costimulatory Blockade and Cyclophosphamide Induces Remission of Systemic Lupus Erythematosus Nephritis in NZB/W F1 Mice by a Mechanism Downstream of Renal Immune Complex Deposition J. Immunol., July 1, 2003; 171(1): 489 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Suh, J. H. Freed, and P. L. Cohen T Cell Reactivity to MHC Class II-Bound Self Peptides in Systemic Lupus Erythematosus-Prone MRL/lpr Mice J. Immunol., February 15, 2003; 170(4): 2229 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L E Schiffer, N Hussain, X Wang, W Huang, J Sinha, M Ramanujam, and A Davidson Lowering anti-dsDNA antibodies--what's new? Lupus, December 1, 2002; 11(12): 885 - 894. [Abstract] [PDF]
|
|
|
|
|
|
C G Katsiari, S-N. Liossis, A M Dimopoulos, D V Charalambopoulos, M Mavrikakis, and P P Sfikakis CD40L overexpression on T cells and monocytes from patients with systemic lupus erythematosus is resistant to calcineurin inhibition Lupus, June 1, 2002; 11(6): 370 - 378. [Abstract] [PDF]
|
|
|
|
|
|
X. Wang, W. Huang, M. Mihara, J. Sinha, and A. Davidson Mechanism of Action of Combined Short-Term CTLA4Ig and Anti-CD40 Ligand in Murine Systemic Lupus Erythematosus J. Immunol., February 15, 2002; 168(4): 2046 - 2053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Yamada, A. D. Salama, and M. H. Sayegh The Role of Novel T Cell Costimulatory Pathways in Autoimmunity and Transplantation J. Am. Soc. Nephrol., February 1, 2002; 13(2): 559 - 575. [Full Text] [PDF]
|
|
|
|
|
|
E. Esfandiari, I. B. McInnes, G. Lindop, F.-P. Huang, M. Field, M. Komai-Koma, X.-q. Wei, and F. Y. Liew A Proinflammatory Role of IL-18 in the Development of Spontaneous Autoimmune Disease J. Immunol., November 1, 2001; 167(9): 5338 - 5347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y H Lee, Y R Kim, J D Ji, J Sohn, and G G Song Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus Lupus, September 1, 2001; 10(9): 601 - 605. [Abstract] [PDF]
|
|
|
|
|
|
B. R. Lawson, S. I. Koundouris, M. Barnhouse, W. Dummer, R. Baccala, D. H. Kono, and A. N. Theofilopoulos The Role of {alpha}{beta}+ T Cells and Homeostatic T Cell Proliferation in Y-Chromosome-Associated Murine Lupus J. Immunol., August 15, 2001; 167(4): 2354 - 2360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Khalil, K. Inaba, R. Steinman, J. Ravetch, and B. Diamond T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus J. Immunol., February 1, 2001; 166(3): 1667 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yi, M. McNerney, and S. K. Datta Regulatory Defects in Cbl and Mitogen-Activated Protein Kinase (Extracellular Signal-Related Kinase) Pathways Cause Persistent Hyperexpression of CD40 Ligand in Human Lupus T Cells J. Immunol., December 1, 2000; 165(11): 6627 - 6634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Mehlhop, M. van de Rijn, J. P. Brewer, A. B. Kisselgof, R. S. Geha, H. C. Oettgen, and T. R. Martin CD40L, but Not CD40, Is Required for Allergen-Induced Bronchial Hyperresponsiveness in Mice Am. J. Respir. Cell Mol. Biol., November 1, 2000; 23(5): 646 - 651. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. M. Annunziata, Y. J. Safiran, S. G. Irving, U. N. Kasid, and J. Cossman Hodgkin disease: pharmacologic intervention of the CD40-NFkappa B pathway by a protease inhibitor Blood, October 15, 2000; 96(8): 2841 - 2848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Villegas, U. Wille, L. Craig, P. S. Linsley, D. M. Rennick, R. Peach, and C. A. Hunter Blockade of Costimulation Prevents Infection-Induced Immunopathology in Interleukin-10-Deficient Mice Infect. Immun., May 1, 2000; 68(5): 2837 - 2844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Liang, R. J. Gee, M. J. Kashgarian, A. H. Sharpe, and M. J. Mamula B7 Costimulation in the Development of Lupus: Autoimmunity Arises Either in the Absence of B7.1/B7.2 or in the Presence of Anti-B7.1/B7.2 Blocking Antibodies J. Immunol., August 15, 1999; 163(4): 2322 - 2329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Peterson, G. C. Sharp, H. Tang, and H. Braley-Mullen B7.2 Has Opposing Roles During the Activation Versus Effector Stages of Experimental Autoimmune Thyroiditis J. Immunol., February 1, 1999; 162(3): 1859 - 1867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. ROSSINI, D. L. GREINER, and J. P. MORDES Induction of Immunologic Tolerance for Transplantation Physiol Rev, January 1, 1999; 79(1): 99 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A N Theofilopoulos Effector and predisposing genes in murine lupus Lupus, November 1, 1998; 7(9): 575 - 584. [Abstract] [PDF]
|
|
|
|
|
|
S K Datta Production of pathogenic antibodies: Cognate interactions between autoimmune T and B cells Lupus, November 1, 1998; 7(9): 591 - 596. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
